Longevity and Wellness
Sermorelin
A provider-directed peptide program described in cautious, non-promissory language.
$179/month
All-inclusive program price · Illustrative demonstration pricing
Product. Product imagery is an illustrative demonstration mock-up; labels, lots, and concentrations shown are not real.
Longevity and Wellness
Tesamorelin Program
A tesamorelin program requiring careful clinician review. Approved indications and proposed program use are not the same thing.
$249/month
All-inclusive program price · Illustrative demonstration pricing
- Online licensed-provider review
- Secure medical intake after checkout
- Ongoing program support by secure message
- Standard shipping
- Routine follow-up required by the program
May be compounded — not FDA-approved
2 mg/vial (illustrative demonstration strength)
Restricted availability. This program requires extended clinical review and may not be offered in your state.
Purchasing a program does not guarantee that a prescription will be issued. If the provider does not approve treatment, the order will be handled according to the ClientRx refund and cancellation policy. Laboratory testing, expedited shipping, replacement products, and third-party services are not included unless specifically stated.
Demonstration notice. ClientRx is a fictional demonstration telehealth brand. Products, pricing, providers, pharmacies, and testimonials shown are illustrative only.
About this program
The ClientRx Tesamorelin Program is presented with an explicit distinction: tesamorelin has a recognised FDA-approved indication in a specific patient population, and any other proposed use is not that indication.
This program is therefore gated behind a closer clinical review than most ClientRx programs. A clinician reviews whether your situation corresponds to an appropriate use, whether laboratory work is needed, and whether treatment should be offered at all.
ClientRx does not market tesamorelin generically as an anti-aging product, a body-recomposition product, or a wellness supplement. Doing so would misrepresent both the evidence and the approval status.
Expect a longer review, additional questions, and a meaningful chance of a decline. That is the correct outcome for a program of this kind when the clinical picture does not fit.
How it may work
Tesamorelin is a growth-hormone-releasing-factor analogue. Its recognised clinical use relates to a specific indication studied in a defined population.
Applying a mechanism outside its studied indication does not carry the same evidence. ClientRx states that plainly rather than borrowing credibility from the approved indication.
No dosing or administration instructions are provided on this site.
Safety summary
- Described effects include injection-site reactions, joint pain, swelling in the extremities, muscle aches, and changes in glucose tolerance.
- Glucose metabolism can be affected. Clinicians typically monitor this where a program proceeds.
- Report swelling, persistent joint pain, or symptoms of high blood sugar to your care team.
This summary is not a complete list of risks and is not medical advice. Visit the safety center. In an emergency, call 911.
Program questions
The active ingredient is approved for a specific indication in a specific population. That is not the same as approval for every marketed use or every compounded formulation.
Related programs
Longevity and Wellness
NAD+
A provider-directed wellness program framed around cellular-energy support, with deliberately cautious claims.
$199/month
All-inclusive program price · Illustrative demonstration pricing
Peptide Programs
CJC-1295
An investigational growth-hormone-releasing peptide shown with a full regulatory disclosure and no outcome claims.
$199/month
All-inclusive program price · Illustrative demonstration pricing